Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436924 · ClinicalTrials.gov registry record
Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
A clinical trial of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
- Recruiting
- Registry status
- 678
- Enrollment target
- 7
- Study locations
NCT06436924: Recruiting study of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
NCT06436924 is a study of Atrial Fibrillation that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 678 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06436924, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.
- RECRUITING
- Registry status
- 678 participants
- Enrollment target
- 7
- Study locations
Study Summary
SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.
Primary Outcome
Incidence of peri-procedural complications summarized descriptively and compared to historical data
Conditions Studied
Interventions
- DEVICE Left Atrial Appendage Device Implant
Study Locations (7)
Florida
- Ascension St. Vincent - Jacksonville
- Naples Community Hospital - Naples
Alabama
- Grandview Medical Center - Birmingham
Arizona
- Pima Heart and Vascular - Tucson
Colorado
- The Medical Center of Aurora - Aurora
Georgia
- Memorial Health University Medical Center - Savannah
South Carolina
- Medical University of South Carolina - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2026-03-30 |
What NCT06436924 shows while recruiting
NCT06436924 is an observational study that tracks outcomes without assigning an intervention. The registered 678 participants enrollment target is mid-sized for trials with a published cap, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Left Atrial Appendage Device Implant is the first listed.
NCT06436924 lists 7 locations in 6 states (Florida, Alabama, Arizona).
Frequently Asked Questions
What is clinical trial NCT06436924 about?
NCT06436924 is a clinical study titled "Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day". SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.
What is the current status of trial NCT06436924?
This trial is currently recruiting. The enrollment target is 678 participants. The study started on 2024-05-14. Estimated completion is 2026-03-30.
What conditions does trial NCT06436924 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT06436924?
The interventions under investigation include: Left Atrial Appendage Device Implant (DEVICE).
Who is sponsoring clinical trial NCT06436924?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06436924 being conducted?
This trial has 7 study locations across Alabama, Arizona, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06436924's enrollment target sits among peer trials
678 44th of 202 higher than 159 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05372484 · 678 participants · NA
Rice Technologies for Cervical Cancer Screening and Diagnosis
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI